Profile data is unavailable for this security.
About the company
Dawnrays Pharmaceutical (Holdings) Ltd is an investment holding company mainly engaged in the development, manufacture and sale of non-patented drugs. The Company operates its business through two segments. The finished drugs segment is engaged in the manufacture and sale of finished drugs. The intermediates and bulk medicines segment is engaged in the manufacture and sale of intermediates and bulk medicines.
- Revenue in HKD (TTM)1.26bn
- Net income in HKD199.86m
- Incorporated2002
- Employees1.12k
- LocationDawnrays Pharmaceutical (Holdings) LtdUnits 3001-02, 30/F, CNT Tower, Wanchai Hong KongHKG
- Phone+852 21119708
- Fax+852 21119870
- Websitehttps://www.dawnrays.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meilleure Health Intrntnl Indu Grp Ltd | 38.10m | 39.17m | 1.01bn | 49.00 | 25.83 | 0.8327 | -- | 26.62 | 0.0096 | 0.0096 | 0.0093 | 0.2978 | 0.0223 | 0.0363 | 0.9608 | 828,173.90 | 2.28 | 2.74 | 2.60 | 3.02 | 72.64 | 47.18 | 102.27 | 28.59 | 2.39 | -- | 0.2211 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| 3D Medicines Inc | 507.84m | -190.85m | 1.05bn | 183.00 | -- | 1.30 | -- | 2.07 | -0.779 | -0.779 | 2.07 | 3.14 | 0.3728 | 7.53 | 6.78 | 2,658,870.00 | -14.79 | -- | -21.47 | -- | 92.11 | -- | -39.68 | -- | 1.59 | -- | 0.205 | -- | -29.81 | -- | 65.19 | -- | -- | -- |
| Transcenta Holding Ltd | 10.66m | -301.67m | 1.08bn | 171.00 | -- | 1.33 | -- | 101.33 | -0.7445 | -0.7445 | 0.0263 | 1.80 | 0.0075 | 0.3793 | 0.4927 | 57,909.79 | -21.21 | -32.48 | -30.08 | -41.13 | 34.76 | 22.08 | -2,831.15 | -1,072.37 | 0.4387 | -408.75 | 0.2437 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 207.23m | 1.13bn | 798.00 | 5.46 | 0.5767 | 4.70 | 1.08 | 0.3699 | 0.3699 | 1.87 | 3.50 | 0.3698 | 2.30 | 3.34 | 1,409,174.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.37bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.26bn | 199.86m | 1.77bn | 1.12k | 8.89 | 0.4741 | 6.00 | 1.41 | 0.1327 | 0.1327 | 0.8371 | 2.49 | 0.2809 | 2.47 | 7.96 | 1,065,846.00 | 4.36 | 10.98 | 5.07 | 13.75 | 45.76 | 55.52 | 15.53 | 32.76 | 4.21 | -- | 0.0028 | 31.01 | -7.89 | 2.22 | 73.29 | 17.20 | 17.13 | 2.69 |
| Cutia Therapeutics | 283.52m | -534.89m | 1.87bn | 298.00 | -- | 1.93 | -- | 6.60 | -1.70 | -1.70 | 0.9023 | 2.67 | 0.1908 | 2.55 | 5.57 | 851,414.80 | -36.00 | -- | -44.42 | -- | 34.92 | -- | -188.66 | -- | 2.92 | -- | 0.2774 | -- | 103.17 | -- | 77.91 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 40.05m | -315.22m | 1.90bn | 270.00 | -- | 0.9779 | -- | 47.34 | -0.5698 | -0.5698 | 0.0725 | 3.54 | 0.0159 | 1.38 | 9.25 | 136,211.20 | -12.50 | -38.02 | -14.65 | -41.79 | 49.28 | -- | -787.13 | -4,412.89 | 4.36 | -29.83 | 0.1373 | -- | 269.73 | -- | 38.32 | -- | 18.80 | -- |
| Jbm (Healthcare) Ltd | 812.98m | 216.39m | 2.29bn | 412.00 | 10.46 | 2.12 | 8.23 | 2.81 | 0.2657 | 0.2657 | 0.9984 | 1.31 | 0.5111 | 3.76 | 5.05 | 2,913,918.00 | 14.09 | 6.57 | 17.00 | 7.83 | 56.76 | 47.82 | 27.56 | 16.60 | 2.41 | -- | 0.2486 | 53.40 | 20.65 | 15.44 | 51.20 | 36.90 | 35.96 | -- |
| Hangzhou Jiuyuan Genetic Biopharm Co Ltd | 1.48bn | 139.79m | 2.32bn | 1.63k | 14.82 | 1.30 | 12.42 | 1.57 | 0.6472 | 0.6472 | 7.24 | 7.37 | 0.7509 | 1.55 | 2.17 | 959,578.90 | 7.10 | -- | 8.88 | -- | 81.67 | -- | 9.45 | -- | 4.03 | 46.31 | 0.1058 | -- | 6.35 | -- | 15.72 | -- | -- | -- |
| Golden Throat Holdings Group Co Ltd | 1.11bn | 303.66m | 2.32bn | 842.00 | 7.64 | 1.70 | 6.80 | 2.09 | 0.4107 | 0.4107 | 1.50 | 1.85 | 0.467 | 2.29 | 5.32 | 1,269,576.00 | 12.78 | 11.71 | 21.02 | 16.75 | 76.42 | 73.08 | 27.37 | 25.87 | 1.73 | 21.95 | 0.3616 | 94.67 | 23.26 | 8.25 | 27.37 | 13.71 | -12.27 | 34.38 |
| Essex Bio-Technology Ltd | 1.73bn | 313.18m | 2.51bn | 1.43k | 8.04 | 1.10 | 6.78 | 1.45 | 0.5508 | 0.5508 | 3.05 | 4.01 | 0.5596 | 2.96 | 2.84 | 1,196,360.00 | 10.10 | 10.28 | 13.56 | 13.62 | 89.50 | 87.73 | 18.05 | 18.70 | 1.82 | -- | 0.1135 | 17.49 | -3.87 | 5.47 | 11.61 | 0.3101 | -7.47 | 7.14 |
| Jacobson Pharma Corporation Ltd | 1.53bn | 302.58m | 2.54bn | 1.79k | 8.36 | 1.14 | 5.63 | 1.66 | 0.1519 | 0.1519 | 0.7698 | 1.12 | 0.4299 | 2.54 | 9.06 | 876,757.00 | 8.48 | 4.83 | 10.29 | 6.17 | 44.30 | 41.26 | 19.73 | 14.85 | 0.9023 | 10.21 | 0.286 | 57.09 | 7.43 | 0.0691 | 43.09 | 7.05 | 24.09 | 14.87 |
| SinoMab Bioscience Ltd | 0.00 | -163.48m | 2.62bn | 61.00 | -- | 8.26 | -- | -- | -0.151 | -0.151 | 0.00 | 0.2288 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
Data as of Feb 13 2026. Currency figures normalised to Dawnrays Pharmaceutical (Holdings) Ltd's reporting currency: Hong Kong Dollar HKD
3.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management (Hong Kong) Ltd.as of 31 Oct 2025 | 37.04m | 2.46% |
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 12.55m | 0.84% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 710.52k | 0.05% |
| DFA Australia Ltd.as of 31 Dec 2025 | 212.52k | 0.01% |
| Acadian Asset Management LLCas of 31 Dec 2025 | 79.49k | 0.01% |
| FIL Investments Internationalas of 30 Jun 2025 | 76.43k | 0.01% |
| American Century Investment Management, Inc.as of 30 Sep 2025 | 7.00k | 0.00% |
| Velten Asset Management GmbHas of 28 Nov 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 28 Nov 2025Source: FactSet Research Systems Inc.
